Review of clinical experience with atosiban and the Tractocile Efficacy Assessment Survey in Europe (TREASURE) study protocol

International Journal of Clinical Practice

Volumn 57, Issue 2, 2003, Pages 121-127

  Husslein, Peter ^a   Quartarolo, J P ^b  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ATOSIBAN; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CORTICOSTEROID; INDOMETACIN; MAGNESIUM SULFATE; OXYTOCIN; OXYTOCIN ANTAGONIST; OXYTOCIN RECEPTOR; PROSTAGLANDIN SYNTHASE INHIBITOR; RITODRINE; UTERUS SPASMOLYTIC AGENT;

BRAIN HEMORRHAGE; CARDIOVASCULAR DISEASE; CLINICAL PRACTICE; CLINICAL PROTOCOL; CLINICAL TRIAL; DISEASE SEVERITY; DRUG EFFICACY; EUROPE; FLUSHING; HEADACHE; HEALTH SURVEY; HUMAN; NAUSEA; NECROTIZING ENTEROCOLITIS; PATIENT SELECTION; PHARMACOEPIDEMIOLOGY; PRACTICE GUIDELINE; PREMATURE LABOR; PRENATAL CARE; PRIORITY JOURNAL; RESPIRATORY DISTRESS SYNDROME; REVIEW; SIDE EFFECT; TREATMENT OUTCOME;

FEMALE; HUMANS; OBSTETRIC LABOR, PREMATURE; PREGNANCY; PROSPECTIVE STUDIES; TOCOLYTIC AGENTS; TREATMENT OUTCOME; VASOTOCIN;

EID: 0037346633     PISSN: 13685031     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (32)

1. Scheider H. Pharmacological intervention in preterm labour. Res Clin Forums 1994; 16: 59-83.
2. Keirse MJ. New perspectives for the effective treatment of preterm labor. Am J Obstet Gynecol 1995; 173: 618-628.
3. Finnstrom O, Olausson PO, Sedin G et al. The Swedish national prospective study on extremely low birthweight (ELBW) infants: incidence, mortality, morbidity and survival in relation to level of care. Acta Paediatr 1997; 86: 503-511.
4. Crowley P, Chalmers I, Keirse MJ. The effects of corticosteroid administration before preterm delivery: an overview of the evidence from controlled trials. Br J Obstet Gynaecol 1990; 97: 11-25.
5. National Institutes of Health. Effect of corticosteroids for fetal maturation on perinatal outcomes: consensus statement. Bethesda, MD: NIH, 1994.
6. Caritis SN, Toig G, Heddinger LS, Ashmead G. A double-blind study comparing ritodrine and terbutaline in the treatment of preterm labor. Am J Obstet Gynecol 1984; 150: 7-14.
7. Kosasa TS, Nakayama RT, Hale RW et al. Ritodrine and terbutaline compared for the treatment of preterm labor. Acta Obstet Gynecol Scand 1985; 64: 421-426.
8. Beall MH, Edgar BW, Paul RH, Smith-Wallace T. A comparison of ritodrine, terbutaline, and magnesium sulfate for the suppression of preterm labor. Am J Obstet Gynecol 1985; 153: 854-862.
9. Miller JM, Keane MD, Horger EO. A comparison of magnesium sulfate and terbutaline for the arrest of premature labor: a preliminary report. J Reprod Med 1982; 27: 348-352.
10. Chan AC, Gabert HA, Miller JM Jr. A prospective comparison of terbutaline and magnesium for tocolysis. Obstet Gynecol 1992; 80: 847-851.
11. Zuckerman H, Shalev E, Gilad G, Katzuni E. Further study of the inhibition of premature labor by indomethacin. Part I: clinical experience. J Perinatol Med 1984; 12: 19-24.
12. Ulmsten U, Andersson KE, Wingerup L. Treatment of premature labor with the calcium antagonist nifedipine. Arch Gynecol 1980; 229: 1-6.
13. Ulmsten U. Treatment of normotensive and hypertensive patients with preterm labor using oral nifedipine, a calcium antagonist. Arch Gynecol 1984; 236: 69-74.
14. Read MD, Wellby DE. The use of a calcium antagonist (nifedipine) to suppress preterm labour. Br J Obstet Gynaecol 1986; 93: 933-937.
15. King JF, Grant A, Keirse MJNC, Chalmers I. Beta-mimetics in preterm labour: an overview of randomised controlled trials. Br J Obstet Gynaecol 1988; 95: 211-222.
16. Cotton DB, Strassner HT, Hill LM et al. Comparison of magnesium sulfate, terbutaline and a placebo for inhibition of preterm labor: a randomized study. J Reprod Med 1984; 29: 92-97.
17. Morales WJ, Smith SG, Angel JL et al. Efficacy and safety of indomethacin versus ritodrine in the management of preterm labour: a randomized study. Obstet Gynecol 1989; 74: 567-753.
18. Morales WJ, Madhav H. Efficacy and safety of indomethacin compared with magnesium sulfate in the management of preterm labor: a randomized study. Am J Obstet Gynecol 1993; 169: 97-102.
19. Papatsonis DNM, Van Geijn HP, Ader HJ et al. Nifedipine and ritodrine in the management of preterm labor: a randomized multicenter trial. Obstet Gynecol 1997; 90: 230-234.
20. Rosen LJ, Zucker D, Oppenheimer-Gazit V, Yagel S. The great tocolytic debate: some pitfalls in the study of safety. Am J Obstet Gynecol 2001; 184: 1-7.
21. Husslein P, Fuchs AR, Fuchs F. Oxytocin and the initiation of human parturition. 1. Prostaglandin release during induction of labor by oxytocin. Am J Obstet Gynecol 1981; 141: 688-693.
22. Fuchs AR, Romero R, Keefe D et al. Oxytocin secretion and human parturition: pulse frequency and duration increase during spontaneous labor in women. Am J Obstet Gynecol 1991; 165: 1515-1523.
23. Goodwin TM, Paul R, Silver H et al. The effect of the oxytocin antagonist atosiban on preterm uterine activity in the human. Am J Obstet Gynecol 1994; 170: 474-478.
24. Goodwin TM, Valenzuela G, Silver H et al. Treatment of preterm labor with the oxytocin antagonist atosiban. Am J Perinatol 1996; 13: 143-146.
25. Romero R, Sibai BM, Sanchez-Ramos L et al. An oxytocin receptor antagonist (atosiban) in the treatment of preterm labor: a randomized, double-blind, placebo-controlled trial with tocolytic rescue. Am J Obstet Gynecol 2000; 182: 1173-1183.
26. The Worldwide Atosiban versus Beta-agonists Study Group. Effectiveness and safety of the oxytocin antagonist versus beta-adrenergic agonists in the treatment of preterm labour. Br J Obstet Gynaecol 2001; 108: 133-142.
27. French/Australian Atosiban Investigators Group. Treatment of preterm labor with the oxytocin antagonist atosiban: a double-blind, randomized, controlled comparison with salbutamol. Eur J Obstet Gynaecol Reprod Biol 2001; 98: 177-85.
28. The European Atosiban Study Group. The oxytocin antagonist atosiban versus the β-agonist terbutaline in the treatment of preterm labor: a randomized, double-blind, controlled study. Acta Obstet Gynecol Scand 2001; 80: 413-422.
29. Moutquin JM, Sherman D, Cohen H et al. Double-blind, randomized, controlled trial of atosiban and ritodrine in the treatment of preterm labor: a multicenter effectiveness and safety study. Am J Obstet Gynecol 2000; 182: 1191-1199.
30. Valenzuela GJ, Sanchez-Ramos L, Romero R et al. Maintenance treatment of preterm labor with the oxytocin antagonist atosiban. Am J Obstet Gynecol 2000; 182: 1184-1190.
31. Sorensen HT, Sabroe S, Olsen J et al. Birthweight and cognitive function in young adult life: historical cohort study. BMJ 1997; 16: 401-403.
32. Helmer H, Brunbauer M, Schatten C et al. Klinische Erfahrungen mit dem Oxytocin Rezeptor Antagonisten Atosiban bei drohender Frühgeburt [Treatment with the oxytocin receptor antagonist atosiban in patients with risk of reterm delivery]. Geburtsch Frauenheilk 2001; 61: 1-6.